Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks

Introduction to Best practice recommendations for the selection and management of patients with MS on natalizumab

(2009) Frederick E Munschauer et al.   Multiple Sclerosis Journal

Clinical vigilance for progressive multifocal leukoencephalopathy in the context of natalizumab use

(2009) Carlo Tornatore et al.   Multiple Sclerosis Journal

Redefining functionality and treatment efficacy in multiple sclerosis

(2009) J. F. Foley et al.   NEUROLOGY

GLANCE: Results of a phase 2, randomized, double-blind, placebo-controlled study

(2009) A. D. Goodman et al.   NEUROLOGY

Memory decline evolves independently of disease activity in MS

(2008) B Duque et al.   Multiple Sclerosis Journal

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire

(2008) RHB Benedict et al.   Multiple Sclerosis Journal

Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study

(2008) B Brochet et al.   Multiple Sclerosis Journal